The Application of a Biphasic Calcium Sulfate Graft Material in Sinus Floor Elevation
Sponsor: Semmelweis University
This observational or N/A phase trial investigates Alveolar Bone Loss and Edentulism Nos and is currently actively recruiting participants. Semmelweis University leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Apr 28, 2026 — Present [daily]
Recruiting
Phase: NA → None
-
Dec 2024 — Apr 2026 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
Pneumatization of the maxillary sinus may lead to insufficient bone volume for dental implant placement in the edentulous posterior maxilla. Sinus floor elevation (SFE) surgery with the lateral window technique is a safe and predictable surgical intervention to restore bone height in the maxillary premolar and molar areas. According to the literature, several bone graft materials may be successfully applied for SFE surgery. There is a lack of evidence regarding the application of biphasic calcium sulfate (BCS) for SFE. The healing period following staged SFE is 2-9 months. The aim of this study is: * to evaluate the success of SFE surgery using BCS as graft material, * to compare the microarchitecture of the augmented bone depending on the healing period, * to evaluate the success of dental implants placed in the augmented bone and that of the prostheses delivered on the dental implants.
Contact Information
- Semmelweis University
For direct contact, visit the study record on ClinicalTrials.gov .